HAYA Therapeutics
SwitzerlandWho owns HAYA Therapeutics?
HAYA Therapeutics is a Swiss Biotech company, currently owned by Earlybird Venture Capital since 2025 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
3 ownership periods · co-invest detected
More from Apollo Health Ventures Fund II
Other portfolio companies in the same fund.
France
United States
United Kingdom
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns HAYA Therapeutics?
HAYA Therapeutics is currently owned by Earlybird Venture Capital, Apollo Health Ventures and 1 other, through Apollo Health Ventures Fund II, since 2025.
When did Earlybird Venture Capital and 2 others acquire HAYA Therapeutics?
Earlybird Venture Capital and 2 others acquired HAYA Therapeutics in 2025.
Who has owned HAYA Therapeutics over time?
HAYA Therapeutics has been through 3 private-equity ownership periods: Apollo Health Ventures · via Apollo Health Ventures Fund II · since 2021; Sofinnova Partners · via Sofinnova Capital X · since 2021; Earlybird Venture Capital · via Earlybird Health · since 2025.